Masahiko Sugimoto   Mineo Kondo   Masayuki Horiguchi   
JOURNAL OF OPHTHALMOLOGY 2013年
Purpose. MaQaid (MaQ) is a new triamcinolone acetonide commercialised in Japan to visualize the vitreous. Because MaQ is preservative-free, it has a lower risk of ocular toxicities. However, since MaQ is only available as a powder, it needs suspen...